Longwei Jiang

817 total citations
14 papers, 653 citations indexed

About

Longwei Jiang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Longwei Jiang has authored 14 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Longwei Jiang's work include RNA modifications and cancer (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Longwei Jiang is often cited by papers focused on RNA modifications and cancer (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Longwei Jiang collaborates with scholars based in China, Australia and United States. Longwei Jiang's co-authors include Hongyi Zhang, Jun Dou, Kai Cai, Fangfang Shi, Xiaoying Wang, Jing Wang, Kai Cheng, Yunxia Zhang, Shaochang Jia and Xiaoyue Zhao and has published in prestigious journals such as Scientific Reports, Stem Cells and Gene Therapy.

In The Last Decade

Longwei Jiang

14 papers receiving 649 citations

Peers

Longwei Jiang
Magali Espinosa Mexico
Isaku Kohama Japan
Nicole Longoni Italy
Sylvia Mahara Singapore
Maša Alečković United States
Yufang Zuo China
Takafumi Kuroda Japan
Xupeng Yue China
Irene K. Guttilla Reed United States
Nicola J. Sunter United Kingdom
Magali Espinosa Mexico
Longwei Jiang
Citations per year, relative to Longwei Jiang Longwei Jiang (= 1×) peers Magali Espinosa

Countries citing papers authored by Longwei Jiang

Since Specialization
Citations

This map shows the geographic impact of Longwei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longwei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longwei Jiang more than expected).

Fields of papers citing papers by Longwei Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longwei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longwei Jiang. The network helps show where Longwei Jiang may publish in the future.

Co-authorship network of co-authors of Longwei Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Longwei Jiang. A scholar is included among the top collaborators of Longwei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longwei Jiang. Longwei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Jiang, Wendi, Qingquan Luo, Xin Tao, et al.. (2024). Combined immunotherapy with dendritic cells and cytokine-induced killer cells for solid tumors: a systematic review and meta-analysis of randomized controlled trials. Journal of Translational Medicine. 22(1). 1122–1122. 5 indexed citations
2.
Chen, Jiannan, Jianhua Hu, Lili Gu, et al.. (2022). Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer. Cancer Immunology Immunotherapy. 72(2). 409–425. 35 indexed citations
3.
Lü, Shuai, Jie Liu, Xiaoxue Zhang, et al.. (2022). Protective effect of γ‐glutamylcysteine against UVB radiation in NIH‐3T3 cells. Photodermatology Photoimmunology & Photomedicine. 38(6). 522–530. 5 indexed citations
4.
Zhang, Miaomiao, Yongjing Yang, Jing Zhang, et al.. (2021). FEN1 inhibitor synergizes with low-dose camptothecin to induce increased cell killing via the mitochondria mediated apoptotic pathway. Gene Therapy. 29(7-8). 407–417. 5 indexed citations
5.
Han, Siqi, Guangchao Li, Meng Jia, et al.. (2021). Delivery of Anti-miRNA-221 for Colorectal Carcinoma Therapy Using Modified Cord Blood Mesenchymal Stem Cells-Derived Exosomes. Frontiers in Molecular Biosciences. 8. 743013–743013. 40 indexed citations
6.
Kathera, Chandrasekhar, Longwei Jiang, Avilala Janardhan, et al.. (2021). Lung cancer: progression of heat shock protein 70 in association with flap endonuclease 1 protein. 3 Biotech. 11(3). 141–141. 1 indexed citations
7.
8.
Liu, Xiaoyu, Longwei Jiang, Meng Jia, et al.. (2020). 32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma. Journal of Translational Medicine. 18(1). 295–295. 41 indexed citations
9.
He, Lingfeng, Zhigang Hu, Miaomiao Zhang, et al.. (2020). PRMT1 is critical to FEN1 expression and drug resistance in lung cancer cells. DNA repair. 95. 102953–102953. 29 indexed citations
10.
Zhao, Xiaoyue, Yanan Zhu, Jianhua Hu, et al.. (2018). Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis. Scientific Reports. 8(1). 14517–14517. 110 indexed citations
11.
Zhang, Hongyi, Kai Cai, Jing Wang, et al.. (2014). MiR-7, Inhibited Indirectly by LincRNA HOTAIR, Directly Inhibits SETDB1 and Reverses the EMT of Breast Cancer Stem Cells by Downregulating the STAT3 Pathway. Stem Cells. 32(11). 2858–2868. 309 indexed citations
12.
Hu, Jianhua, et al.. (2014). The clinical effects of dendritic cell vaccines combined with cytokine-induced killer cells intraperitoneal injected on patients with malignant ascites.. PubMed. 7(11). 4272–81. 17 indexed citations
13.
Dou, Jun, Hongyi Zhang, Jing Wang, et al.. (2012). Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells. Journal of Cancer Research and Therapeutics. 8(2). 226–226. 29 indexed citations
14.
Hu, Weihua, Xiangfeng He, Hongyi Zhang, et al.. (2011). Human umbilical blood mononuclear cell–derived mesenchymal stem cells serve as interleukin‐21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice. Biotechnology and Applied Biochemistry. 58(6). 397–404. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magali Espinosa Breakdown of academic impact, for papers by Isaku Kohama Breakdown of academic impact, for papers by Nicole Longoni Breakdown of academic impact, for papers by Sylvia Mahara Breakdown of academic impact, for papers by Maša Alečković Breakdown of academic impact, for papers by Yufang Zuo Breakdown of academic impact, for papers by Takafumi Kuroda Breakdown of academic impact, for papers by Xupeng Yue Breakdown of academic impact, for papers by Irene K. Guttilla Reed Breakdown of academic impact, for papers by Nicola J. Sunter
Rankless by CCL
2026